2024 · Lancet · open access
Novel lateral flow assay for point-of-care detection of Neisseria gonorrhoeae infection in syndromic management settings: a cross-sectional performance evaluation
Peters et al.
The finding, in our words
The novel lateral flow assay demonstrated excellent clinical sensitivity and specificity for detecting Neisseria gonorrhoeae in first-void urine and vaginal swabs, meeting the target product profile for a rapid point-of-care test. This decentralised diagnostic tool could optimise clinical management and reduce unnecessary antibiotic use in primary care settings lacking laboratory infrastructure.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.